BlackRock’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-9,813,602
Closed -$30.9M 5295
2020
Q3
$30.9M Sell
9,813,602
-148,332
-1% -$474K ﹤0.01% 2599
2020
Q2
$29M Buy
9,961,934
+5,182
+0.1% +$16.4K ﹤0.01% 2603
2020
Q1
$28.1M Sell
9,956,752
-818,250
-8% -$2.64M ﹤0.01% 2420
2019
Q4
$35M Sell
10,775,002
-310,726
-3% -$902K ﹤0.01% 2573
2019
Q3
$23.9M Buy
11,085,728
+31,238
+0.3% +$83.5K ﹤0.01% 2716
2019
Q2
$34.7M Sell
11,054,490
-1,294,598
-10% -$4.2M ﹤0.01% 2541
2019
Q1
$45.9M Sell
12,349,088
-237,665
-2% -$802K ﹤0.01% 2325
2018
Q4
$36.5M Buy
12,586,753
+71,710
+0.6% +$197K ﹤0.01% 2409
2018
Q3
$32.9M Sell
12,515,043
-1,503,409
-11% -$3.69M ﹤0.01% 2601
2018
Q2
$32.8M Sell
14,018,452
-574,932
-4% -$1.61M ﹤0.01% 2595
2018
Q1
$42.9M Sell
14,593,384
-118,579
-0.8% -$324K ﹤0.01% 2358
2017
Q4
$40.3M Buy
14,711,963
+713,150
+5% +$2.19M ﹤0.01% 2417
2017
Q3
$47.5M Sell
13,998,813
-785,697
-5% -$2.18M ﹤0.01% 2331
2017
Q2
$36.5M Buy
14,784,510
+399,864
+3% +$920K ﹤0.01% 2447
2017
Q1
$32.7M Buy
14,384,646
+14,327,235
+24,956% +$31.7M ﹤0.01% 2467
2016
Q4
$122K Sell
57,411
-86,111
-60% -$240K ﹤0.01% 2434
2016
Q3
$480K Buy
143,522
+6,072
+4% +$19.3K ﹤0.01% 1753
2016
Q2
$431K Buy
137,450
+116,821
+566% +$390K ﹤0.01% 1730
2016
Q1
$69K Sell
20,629
-28,623
-58% -$89.2K ﹤0.01% 2197
2015
Q4
$173K Buy
49,252
+498
+1% +$2.08K ﹤0.01% 1681
2015
Q3
$245K Sell
48,754
-23,675
-33% -$136K ﹤0.01% 1604
2015
Q2
$465K Buy
72,429
+3,477
+5% +$23.3K ﹤0.01% 1561
2015
Q1
$485K Buy
68,952
+32,225
+88% +$233K ﹤0.01% 1528
2014
Q4
$283K Sell
36,727
-10,137
-22% -$80.2K ﹤0.01% 1438
2014
Q3
$350K Buy
46,864
+9,947
+27% +$92.4K ﹤0.01% 1408
2014
Q2
$357K Sell
36,917
-39
-0.1% -$348 ﹤0.01% 1388
2014
Q1
$308K Buy
36,956
+5,036
+16% +$43.2K ﹤0.01% 1432
2013
Q4
$270K Buy
31,920
+27,060
+557% +$228K ﹤0.01% 1530
2013
Q3
$39K Hold
4,860
﹤0.01% 1947
2013
Q2
$38K Buy
+4,860
New +$37.9K ﹤0.01% 1981

Other funds holding PDLI